Aims and scope
Harm Reduction Journal publishes research focusing on the prevalent patterns of psychoactive drug use, the public policies meant to control them, and the search for effective methods of reducing the adverse medical, public health, and social consequences associated with both drugs and drug policies. We define 'harm reduction' as 'policies and programs which aim to reduce the health, social, and economic costs of legal and illegal psychoactive drug use without necessarily reducing drug consumption'.
We are especially interested in studies of the evolving patterns of drug use around the world, their implications for the spread of HIV/AIDS and other blood-borne pathogens, and in accurate descriptions and rigorous evaluations of innovative policies and practices for harm reduction in diverse societies. Harm Reduction Journal also seeks to improve the access to authoritative and current harm reduction literature for health professionals and policy specialists in the non-English speaking world, by offering access to translations of published articles, and their data sets.
Although many journals already publish on issues around drug use, the open access journal Harm Reduction Journal is the first to focus exclusively on this public health model and to make contemporary research on harm reduction freely available online - as well as providing full access to the large body of factual reports and policy documents published by governments and by the growing international network of harm reduction organizations.
All articles published by Harm Reduction Journal are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Harm Reduction Journal you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Harm Reduction Journal therefore levies an article-processing charge of £1790.00/$2570.00/€2040.00 for each article accepted for publication, plus VAT or local taxes where applicable.
If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
BMC provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
All articles published in Harm Reduction Journal are included in:
- Current contents
- PubMed Central
- Social Sciences Citation Index
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
Harm Reduction Journal operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
All manuscripts submitted to Harm Reduction Journal should adhere to BioMed Central's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Citing articles in Harm Reduction Journal
Articles in Harm Reduction Journal should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Harm Reduct J [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Harm Reduct J 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Appeals and complaints
If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher.
Why publish your article in Harm Reduction Journal
Harm Reduction Journal's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
Harm Reduction Journal offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in Harm Reduction Journal gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Harm Reduction Journal are included in article alerts and regular email updates. Some may be highlighted on Harm Reduction Journal’s pages and on the BioMed Central homepage.
In addition, articles published in Harm Reduction Journal may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Harm Reduction Journal. A list of articles recently press-released by journals published by BioMed Central is available here.
As an author of an article published in Harm Reduction Journal you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.
Annual Journal Metrics
58 days to first decision for reviewed manuscripts only
51 days to first decision for all manuscripts
94 days from submission to acceptance
21 days from acceptance to publication
2253 Altmetric mentions